European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly summary in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status

Include:

Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:

/

Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Actos

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 13/10/2000           Authorised
Competact

pioglitazone / metformin hydrochloride

Diabetes Mellitus, Type 2 28/07/2006           Authorised
Glidipion (previously Pioglitazone Actavis Group)

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 15/03/2012           Authorised
Glubrava

metformin hydrochloride / pioglitazone hydrochloride

Diabetes Mellitus, Type 2 11/12/2007           Authorised
Glustin

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 11/10/2000           Authorised
Incresync

alogliptin / pioglitazone

Diabetes Mellitus, Type 2 19/09/2013           Authorised
Paglitaz

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 21/03/2012           Withdrawn
Pioglitazone Accord

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 21/03/2012           Authorised
Pioglitazone Actavis

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 15/03/2012           Authorised
Pioglitazone Krka

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 21/03/2012           Withdrawn
Pioglitazone Teva

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 26/03/2012           Authorised
Pioglitazone Teva Pharma

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 26/03/2012           Authorised
Sepioglin

pioglitazone hydrochloride

Diabetes Mellitus, Type 2 09/03/2012           Withdrawn
Tandemact

pioglitazone / glimepiride

Diabetes Mellitus, Type 2 08/01/2007           Authorised